# Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)

> **NCT04896866** · NA · COMPLETED · sponsor: **University of Alberta** · enrollment: 833 (actual)

## Conditions studied

- Covid19
- COVID-19 Pneumonia
- COVID-19 Lower Respiratory Infection
- COVID-19 Acute Respiratory Distress Syndrome
- SARS-CoV2 Infection
- SARS-CoV-2 Acute Respiratory Disease

## Interventions

- **BEHAVIORAL:** Antimicrobial stewardship prospective audit and feedback

## Key facts

- **NCT ID:** NCT04896866
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2021-10-15
- **Final completion:** 2021-11-30
- **Target enrollment:** 833 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04896866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04896866, "Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04896866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*